Deoxyhypusine synthase haploinsufficiency attenuates acute cytokine signaling

Cell Cycle

Volumn 10, Issue 7, 2011, Pages 1043-1049

  Templin, Andrew T ^a   Maier, Bernhard ^a   Nishiki, Yurika ^a   Tersey, Sarah A ^a   Mirmira, Raghavendra G ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Diabetes; Hypusine; Inflammation; mRNA translation; Posttranslational modification

Indexed keywords

ANTIDIABETIC AGENT; DEOXYHYPUSINE SYNTHASE; GAMMA INTERFERON; GLUCOSE; HYPUSINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INITIATION FACTOR 5A; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; N' GUANYL 1,7 DIAMINOHEPTANE; TRANSFERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELLULAR STRESS RESPONSE; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST; GENE EXPRESSION REGULATION; GENE INACTIVATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HETEROZYGOSITY; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

EUKARYOTA; MUS;

EID: 79953662744     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.7.15206     Document Type: Review

References (37)

1. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116:1802-12. (Pubitemid 44033300)
2. Fontés G, Zarrouki B, Hagman DK, Latour MG, Semache M, Roskens V, et al. Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass. Diabetologia 2010; 53:2369-79.
3. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. Islet-Associated macrophages in type 2 diabetes. Diabetologia 2009; 52:1686-8.
4. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15:914-20.
5. Huang CJ, Lin CY, Haataja L, Gurlo T, Butler AE, Rizza RA, et al. High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress mediated beta-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 2007; 56:2016-27. (Pubitemid 47201819)
6. Zraika S, Hull RL, Udayasankar J, Aston-Mourney K, Subramanian SL, Kisilevsky R, et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 2009; 52:626-35.
7. Ogihara T, Mirmira RG. An islet in distress: B cell failure in type 2 diabetes. J Diab Invest 2010; 1:123-33.
8. Chambers KT, Unverferth JA, Weber SM, Wek RC, Urano F, Corbett JA. The role of nitric oxide and the unfolded protein response in cytokine-induced betacell death. Diabetes 2008; 57:124-32.
9. Hughes KJ, Chambers KT, Meares GP, Corbett JA. Nitric oxides mediates a shift from early necrosis to late apoptosis in cytokine-treated {beta}-cells that is associated with irreversible DNA damage. Am J Physiol Endocrinol Metab 2009.
10. Poitout V, Amyot J, Semache M, Zarrouki B, Hagman D, Fontés G. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta 2009.
11. Perl S, Kushner JA, Buchholz BA, Meeker AK, Stein GM, Hsieh M, et al. Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J Clin Endocrinol Metab 2010; 95:234-9.
12. Leiter EH, Coleman DL, Hummel KP. The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. III. Effect of H-2 haplotype and sex. Diabetes 1981; 30:1029-34.
13. Baetens D, Stefan Y, Ravazzola M, Malaisse-Lagae F, Coleman DL, Orci L. Alteration of islet cell populations in spontaneously diabetic mice. Diabetes 1978; 27:1-7. (Pubitemid 8293466)
14. Robbins RD, Tersey SA, Ogihara T, Gupta D, Farb TB, Ficorilli J, et al. Inhibition of deoxyhypusine synthase enhances islet {beta} cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes. J Biol Chem 2010; 285:39943-52.
15. Clement PM, Henderson CA, Jenkins ZA, Smit-McBride Z, Wolff EC, Hershey JW, et al. Identification and characterization of eukaryotic initiation factor 5A-2. Eur J Biochem 2003; 270:4254-63. (Pubitemid 37340343)
16. Li CH, Ohn T, Ivanov P, Tisdale S, Anderson P. Eif5A promotes translation elongation, polysome disassembly and stress granule assembly. PLoS One 2010; 5:9942.
17. Saini P, Eyler DE, Green R, Dever TE. Hypusine- Containing protein eif5a promotes translation elongation. Nature 2009; 459:118-21.
18. Kang HA, Hershey JW. Effect of initiation factor eif-5a depletion on protein synthesis and proliferation of saccharomyces cerevisiae. J Biol Chem 1994; 269:3934-40. (Pubitemid 24237736)
19. Rosorius O, Reichart B, Kratzer F, Heger P, Dabauvalle MC, Hauber J. Nuclear pore localization and nucleocytoplasmic transport of eif-5a: Evidence for direct interaction with the export receptor CRM1. J Cell Sci 1999; 112:2369-80. (Pubitemid 29381027)
20. Jao DL, Yu Chen K. Subcellular localization of the hypusine-containing eukaryotic initiation factor 5A by immunofluorescent staining and green fluorescent protein tagging. J Cell Biochem 2002; 86:590-600. (Pubitemid 36076175)
21. Lipowsky G, Bischoff FR, Schwarzmaier P, Kraft R, Kostka S, Hartmann E, et al. Exportin 4: A mediator of a novel nuclear export pathway in higher eukaryotes. EMBO J 2000; 19:4362-71. (Pubitemid 30623747)
22. Maier B, Ogihara T, Trace AP, Tersey SA, Robbins RD, Chakrabarti SK, et al. The unique hypusine modification of eif5a promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 2010; 120:2156-70.
23. Park MH, Nishimura K, Zanelli CF, Valentini SR. Functional significance of eif5a and its hypusine modification in eukaryotes. Amino Acids 2010; 38:491-500.
24. Jakus J, Wolff EC, Park MH, Folk JE. Features of the spermidine-binding site of deoxyhypusine synthase as derived from inhibition studies. Effective inhibition by bis- and mono-guanylated diamines and polyamines. J Biol Chem 1993; 268:13151-9. (Pubitemid 23307731)
25. Umland TC, Wolff EC, Park MH, Davies DR. A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme. NAD. Inhibitor ternary complex. J Biol Chem 2004; 279:28697-705. (Pubitemid 38900154)
26. Lee Y, Kim HK, Park HE, Park MH, Joe YA. Effect of n1-guanyl-1,7- diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis. Mol Cell Biochem 2002; 237:69-76. (Pubitemid 34965794)
27. Nishimura K, Murozumi K, Shirahata A, Park MH, Kashiwagi K, Igarashi K. Independent roles of eif5a and polyamines in cell proliferation. Biochem J 2005; 385:779-85. (Pubitemid 40208839)
28. Park MH, Wolff EC, Lee YB, Folk JE. Antiproliferative effects of inhibitors of deoxyhypusine synthase. Inhibition of growth of chinese hamster ovary cells by guanyl diamines. J Biol Chem 1994; 269:27827-32.
29. Chatterjee I, Gross SR, Kinzy TG, Chen KY. Rapid depletion of mutant eukaryotic initiation factor 5A at restrictive temperature reveals connections to actin cytoskeleton and cell cycle progression. Mol Genet Genomics 2006; 275:264-76. (Pubitemid 43357663)
30. Zanelli CF, Valentini SR. Pkc1 acts through zds1 and gic1 to suppress growth and cell polarity defects of a yeast eif5a mutant. Genetics 2005; 171:1571-81.
31. Patel PH, Costa-Mattioli M, Schulze KL, Bellen HJ. The drosophila deoxyhypusine hydroxylase homologue nero and its target eif5a are required for cell growth and the regulation of autophagy. J Cell Biol 2009; 185:1181-94.
32. Hanauske-Abel HM, Park MH, Hanauske AR, Popowicz AM, Lalande M, Folk JE. Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim Biophys Acta 1994; 1221:115-24. (Pubitemid 24103809)
33. Moore CC, Martin EN, Lee G, Taylor C, Dondero R, Reznikov LL, et al. Eukaryotic translation initiation factor 5A small interference rna-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injury. J Infect Dis 2008; 198:1407-14.
34. Klier H, Csonga R, Joäo HC, Eckerskorn C, Auer M, Lottspeich F, et al. Isolation and structural characterization of different isoforms of the hypusine-containing protein eif-5a from hela cells. Biochemistry 1995; 34:14693-702.
35. Gerner EW, Mamont PS, Bernhardt A, Siat M. Post- Translational modification of the protein-synthesis initiation factor eif-4d by spermidine in rat hepatoma cells. Biochem J 1986; 239:379-86. (Pubitemid 16008458)
36. Gosslau A, Jao DL, Butler R, Liu AY, Chen KY. Thermal killing of human colon cancer cells is associated with the loss of eukaryotic initiation factor 5A. J Cell Physiol 2009; 219:485-93.
37. Lee SB, Park JH, Kaevel J, Sramkova M, Weigert R, Park MH. The effect of hypusine modification on the intracellular localization of eif5a. Biochem Biophys Res Commun 2009; 383:497-502.